1.Skrgatić, Lana, Baldani, Dinka Pavičić, et al. (2013) Genetic polymorphisms of ins, insr and irs-1 genes are not associated with polycystic ovary syndrome in croatian women. Collegium Antropologicum, 37(1), 141-146.
2. Ciaraldi, T. P. (2000) Molecular defects of insulin action in the polycystic ovary syndrome: possible tissue specificity. J Pediatr Endocrinol Metab, 13 Suppl 5, 1291-1293.
3. Diamanti-Kandarakis, E., Argyrakopoulou, G., Economou, F. , Kandaraki, E. , Koutsilieris, M. . (2008). Defects in insulin signaling pathways in ovarian steroidogenesis and other tissues in polycystic ovary syndrome (pcos). Journal of Steroid Biochemistry & Molecular Biology, 109(3-5), 242-246.
[4] Torres, P. J., Siakowska, M., Banaszewska, B., Pawelczyk, L., Duleba, A. J., Kelley, S. T., & Thackray, V. G. (2018). Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism. The Journal of Clinical Endocrinology and Metabolism, 103(4), 1502-1511.
[5] Lindheim, L. , Bashir, M. , Julia Mü Nzker, Trummer, C. , & Obermayer-Pietsch, B. . (2017). Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (pcos): a pilot study. Plos One, 12(1), e0168390.
[6] Rui, L. , Chenhong, Z. , Yu, S. , Feng, Z. , Linxia, L. , & Xuejiao, W. , et al. (2017). Dysbiosis of gut microbiota associated with clinical parameters in polycystic ovary syndrome. Frontiers in Microbiology, 8, 324.
[7] Zhang, D., Zhang, L., Yue, F., Zheng, Y., & Russell, R. D. (2014). Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation.. European Journal of Endocrinology, 172(1), 29-36.
[8] Tremellen, K., & Pearce, K. (2012). Dysbiosis of Gut Microbiota (DOGMA)--a novel theory for the development of Polycystic Ovarian Syndrome.. Medical Hypotheses, 79(1), 104-112.
[9] Harada, N., Hanaoka, R., Horiuchi, H., Kitakaze, T., Mitani, T., Inui, H., & Yamaji, R. (2016). Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice.. Scientific Reports, 6(1), 23001-23001.
[10] Kafali, H., Iriadam, M., Ozardali, I., & Demir, N. (2004). Letrozole-induced polycystic ovaries in the rat: A new model for cystic ovarian disease. Archives of Medical Research, 35(2), 103-108.
[11] Corbin, C. J., Trant, J. M., Walters, K. W., & Conley, A. J. (1999). Changes in Testosterone Metabolism Associated with the Evolution of Placental and Gonadal Isozymes of Porcine Aromatase Cytochrome P450. Endocrinology, 140(11), 5202-5210.
[12] Manneras, L., Cajander, S., Holmang, A., Seleskovic, Z., Lystig, T. C., Lonn, M., & Stenervictorin, E. (2007). A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome. Endocrinology, 148(8), 3781-3791.
[13] Apter, D. (1998). How possible is the prevention of polycystic ovary syndrome development in adolescent patients with early onset of hyperandrogenism. Journal of Endocrinological Investigation, 21(9), 613-617.
[14] Crosignani, P. G., & Nicolosi, A. E. (2001). Polycystic ovarian disease: heritability and heterogeneity. Human Reproduction Update, 7(1), 3-7.
[15] Franks, S., Mccarthy, M. I., & Hardy, K. (2006). Development of polycystic ovary syndrome: involvement of genetic and environmental factors.. International Journal of Andrology, 29(1), 278-285.
[16] Fassnacht, M., Schlenz, N., Schneider, S. B., Wudy, S. A., Allolio, B., & Arlt, W. (2003). Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5α-Reductase Activity in Women with Polycystic Ovary Syndrome. The Journal of Clinical Endocrinology and Metabolism, 88(6), 2760-2766.
[17] Silfen, M. E. , Denburg, M. R. , Manibo, A. M. , Lobo, R. A. , Richard, J. , & Michel, F. , et al. (0). Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (pcos): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab(10), 4682-4688.
[18] Shi, D., & Vine, D. F. (2012). Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Fertility and Sterility, 98(1), 185-193.
[19] Aleshin, A. E. , Zeng, C. , Bourenkov, G. P. , Bartunik, H. D. , Fromm, H. J. , & Honzatko, R. B. . (1998). The mechanism of regulation of hexokinase: new insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate. Structure, 6(1), 39.
[20] Louvet JP, Harman SM, Schrieber JR, & Ross GT. (1975). Evidence of a role of adrogens in follicular maturation. Endocrinology, 97(2), 366.
[21] Cullberg, G., Hamberger, L., Mattsson, L., Mobacken, H., & Samsioe, G. (1985). Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel–ethinylestradiol combination. Acta Obstetricia et Gynecologica Scandinavica, 64(3), 203-207.
[22] Berneis, K. , Rizzo, M. , Hersberger, M. , Rini, G. B. , & Carmina, E. . (2010). Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. International Journal of Clinical Practice, 63(1), 56-62.
[23] Carmina, E., Chu, M. C., Longo, R. A., Rini, G. B., & Lobo, R. A. (2005). Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters.. The Journal of Clinical Endocrinology and Metabolism, 90(5), 2545-2549.
[24] Salim, S., Sarraj, N., Taneja, M., Saha, K., Tejadasimon, M. V., & Chugh, G. (2010). Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats.. Behavioural Brain Research, 208(2), 545-552.
[25] Salim, S. (2014). Oxidative stress and psychological disorders.. Current Neuropharmacology, 12(2), 140-147.
[26] Hu, S., Jia, X., Li, J., Zheng, X., Ao, J., Liu, G., ... & Zhao, M. (2016). T cell infiltration is associated with kidney injury in patients with anti-glomerular basement membrane disease. Science China-life Sciences, 59(12), 1282-1289.
[27] Lee, J. Y., Baw, C., Gupta, S., Aziz, N., & Agarwal, A. (2010). Role of Oxidative Stress in Polycystic Ovary Syndrome. Current Women's Health Reviews, 6(2), 96-107. [28] Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007). Polycystic Ovary Syndrome and its Developmental Origins. Reviews in Endocrine & Metabolic Disorders, 8(2), 127-141.
[29] Franks, S., & Mccarthy, M. I. (2004). Genetics of Ovarian Disorders: Polycystic Ovary Syndrome. Reviews in Endocrine & Metabolic Disorders, 5(1), 69-76.
[30] Guo, Y., Qi, Y., Yang, X., Zhao, L., Wen, S., Liu, Y., & Tang, L. (2016). Association between Polycystic Ovary Syndrome and Gut Microbiota. PLOS ONE, 11(4).
[31] Markle, J. G., Frank, D. N., Mortintoth, S. M., Robertson, C. E., Feazel, L. M., Rollekampczyk, U., ..& Danska, J. S. (2013). Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity. Science, 339(6123), 1084-1088.
[32] Org, E., Mehrabian, M., Parks, B. W., Shipkova, P., Liu, X., Drake, T. A., & Lusis, A. J. (2016). Sex differences and hormonal effects on gut microbiota composition in mice. Gut microbes, 7(4), 313-322.
[33] Tilman, D., Reich, P. B., Knops, J. M., Wedin, D. A., Mielke, T., & Lehman, C. (2001). Diversity and Productivity in a Long-Term Grassland Experiment. Science, 294(5543), 843-845.
[34] Walters, W. A., Xu, Z., & Knight, R. (2014). Meta-analyses of human gut microbes associated with obesity and IBD. FEBS Letters, 588(22), 4223-4233.
[35] Finucane, M. M., Sharpton, T. J., Laurent, T., & Pollard, K. S. (2014). A Taxonomic Signature of Obesity in the Microbiome? Getting to the Guts of the Matter. PLOS ONE, 9(1).
[36] Sze, M. A., & Schloss, P. D. (2016). Looking for a Signal in the Noise: Revisiting Obesity and the Microbiome. Mbio, 7(4).
[37] Xu, J., Bjursell, M. K., Himrod, J., Deng, S., Carmichael, L. K., Chiang, H. C., ... & Gordon, J. I. (2003). A Genomic View of the Human-Bacteroides thetaiotaomicron Symbiosis. Science, 299(5615), 2074-2076.
[38] Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature, 444(7122), 1027-1031.
[39] Agnieszka, M. , Will, V. T. , González Antonio, Herrera, J. J. , Rob, K. , & Monika, F. , et al. (2015). Exercise is more effective at altering gut microbial composition and producing stable changes in lean mass in juvenile versus adult male f344 rats. Plos One, 10(5), e0125889.
[40] Federico, A. , Dallio, M. , Sarno, R. D. , Giorgio, V. , & Miele, L. . (2017). Gut microbiota, obesity and metabolic disorders. Minerva Gastroenterologica e Dietologica, 63(4), 337-344.
[41] Jiao, X., Wang, Y., Lin, Y., Lang, Y., Li, E., Zhang, X., ... & Li, B. (2019). Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota.. Journal of Nutritional Biochemistry,, 88-100.
[42] Chen, L. , Zhang, L. , Wang, W. , Qiu, W. , & Zhong, M. . (2020). Polysaccharides isolated from cordyceps sinensis contribute to the progression of nash by modifying the gut microbiota in mice fed a high-fat diet. PLoS ONE, 15(6), e0232972.
[43] Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015). CheckM: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Research, 25(7), 1043-1055.
[44] Kearse, M. , Moir, R. , Wilson, A. , Stones-Havas, S. , & Drummond, A. . (2012). Geneious basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics, 28(12), 1647-1649.
[45] Zheng, J. , Yuan, X. , Cheng, G. , Jiao, S. , Feng, C. , & Zhao, X. , et al. (2018). Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice. Carbohydrate Polymers, 190, 77-86.
[46] Li, Z. , Yi, C. , Fangzhen, X. , Buatikamu, A. , Wen, Z. , & Yuyu, G. , et al. (2018). A glucagon-like peptide-1 receptor agonist lowers weight by modulating the structure of gut microbiota. Frontiers in Endocrinology, 9, 233.
[47] Zhiguo, Z. , Yanjing, C. , Lihua, X. , Zhen, W. , Gary, X. , & Jingqing, H. . (2017). Effect of curcumin on the diversity of gut microbiota in ovariectomized rats. Nutrients, 9(10), 1146.
[48] Tao, Z., Xu, W., Zhu, C., Zhang, S., Shi, Z., Song, W., ... & Li, H. (2019). Effects of ammonia on intestinal microflora and productive performance of laying ducks. Poultry Science, 98(5), 1947-1959.
[49] Conley, M. N. , Wong, C. P. , Duyck, K. M. , Hord, N. , & Sharpton, T. J. . (2016). Aging and serum mcp-1 are associated with gut microbiome composition in a murine model. Peerj, 4(Supplement 2), e1854.
[50] Xie, J. , Liu, Y. , Chen, B. , Zhang, G. , Ou, S. , & Luo, J. , et al. (2019). Ganoderma lucidum polysaccharide improves rat dss-induced colitis by altering cecal microbiota and gene expression of colonic epithelial cells. Food, Nutrition Research, 63.
[51] Venkatraman A, Ramakrishna BS, Shaji RV, Kumar NS, Pulimood A, & Patra S. (2003). Amelioration of dextran sulfate colitis by butyrate: role of heat shock protein 70 and nf-kappab. Am J Physiol Gastrointest Liver Physiol, 285(1), 177-84.
[52] Gao H, Jiang Q, Ji H, Ning J, Li C, Zheng H. (2019).Type 1 diabetes induces cognitive dysfunction in rats associated with alterations of the gut microbiome and metabolomes in serum and hippocampus. Biochim Biophys Acta Mol Basis Dis, 1865(12):165541.